20 Jul 2026 MHRA touts uptick in approvals in 2025-2026 annual report The UK's Medicines and Healthcare products Regulatory Agency (MHRA) touted its achievements over the last year its 2025-2026 annual report to Parliament, which includes approving more new drugs than the prior year, removing a record number of illegal drugs from circulation, and taking steps to advance the regulation of artificial intelligence (AI) in healthcare. Regulatory News
68 words · extracted 19h agoread original ↗
comments(0)
5-min edit window · permanent after that